Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal
Abbott Laboratories is selling corporate bonds in as many as eight parts to help fund its around $21 billion acquisition of cancer-screening company Exact Sciences Corp.
By Brian W Smith, Michael Gambale · Bloomberg Markets
Abbott Laboratories is selling corporate bonds in as many as eight parts to help fund its around $21 billion acquisition of cancer-screening company Exact Sciences Corp.